Background The safety and efficacy of antenatal glucocorticoids in women in low-resource
countries who are at risk for preterm birth are uncertain. Methods We conducted a …

Background There is currently insufficient evidence on the safety and efficacy of antenatal
corticosteroids in preventing mortality and severe morbidity amongst late preterm newborns …

Background Antenatal corticosteroids given to women before preterm birth improve infant
survival and health. However, whether dexamethasone or betamethasone have better …

Background Antenatal corticosteroids for pregnant women at risk of preterm birth are among
the most effective hospital-based interventions to reduce neonatal mortality. We aimed to …

Objective To evaluate the effectiveness of antenatal corticosteroids given at≥ 34 weeks'
gestation. Design Systematic review with meta-analysis. Data sources Electronic databases …

Background Despite the global burden of morbidity and mortality associated with preterm
birth, little evidence is available for use of antenatal corticosteroids and tocolytic drugs in …

The most beneficial interventions available are those that improve newborn outcomes when
preterm birth is inevitable (tertiary interventions) and those that focus on special care for …

Background Respiratory distress syndrome is a serious complication of prematurity causing
significant immediate and long‐term mortality and morbidity. Objectives The objective of this …

OBJECTIVE. Antenatal dexamethasone and betamethasone may not be equally efficacious
in the prevention of adverse neonatal outcomes. We compared the risks of periventricular …

Background This study synthesizes available evidence on antenatal corticosteroids (ACS)
use among special subgroups of women at risk of imminent preterm birth, including those (1) …